SITC Archive Library

On Monday, June 21, 2021 from 4 – 5 pm ET, leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel presented "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma." This high-level webinar was designed so that attendees will know how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease.

Webinar Faculty:

• Moderator: David L. Porter, MD – University of Pennsylvania (Expert Panel Member)
• Justin P. Kline, MD – University of Chicago (Expert Panel Member)
• Koen van Besien, MD, PhD – Weill Cornell Medicine (Expert Panel Member)

The webinar discussed:

• Prioritizing immunotherapy treatment options, including sequencing of CAR T and ICIs with stem cell transplantation
• Curative potential of CAR T and how to predict success or failure of CAR T treatments
• Outcomes of using CAR T in earlier lines of treatment
• Toxicities of CAR T therapies

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. 

This webinar is supported, in part, by independent medical education grant funding from 
(as of 6/7/21)

#Lymphoma #RecordedWebinar #2021 #ClinicalPracticeGuideline #Tcells #Toxicities #ImmuneCheckpointInhibitors